Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore Medical Dialogues Bureau3 Nov 2019 9:30 AM ISTRevenue in the second quarter stood at Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period, an increase of 26.41 per cent, Dr Reddy's...
Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma Medical Dialogues Bureau2 Nov 2019 9:15 AM ISTConsolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
GSK Pharma reports Q2 profit at Rs 503 crore Medical Dialogues Bureau1 Nov 2019 9:15 AM ISTGSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 9:30 AM ISTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2 Medical Dialogues Bureau28 Oct 2019 9:30 AM ISTAlembic said its international formulations grew 10 per cent to Rs 646 crore in the quarter under review and 17 per cent to Rs 1,099 crore in the...
Strides Pharma reports revenue of Rs 718 crore for Q2 Medical Dialogues Bureau27 Oct 2019 9:32 AM ISTEBITDA margins stood at 21 per cent, up by 300 basis point quarter-on-quarter and 1,170 bps year-on-year. EBITDA margin expansion was led by good...
Syngene reports robust 11% YOY revenue growth in Q2 FY20 Medical Dialogues Bureau23 Oct 2019 12:18 PM ISTBengaluru: Syngene International Limited recently announced its Q2 FY20 results posting quarterly revenue of Rs. 485 Cr, an increase of 11% from the...
Cipla shareholders approve raising up to Rs 3,000 cr Medical Dialogues Bureau19 Aug 2019 3:34 PM ISTNew Delhi: Indian Drug major Cipla on Saturday said its shareholders have approved a proposal to raise up to Rs 3,000 crore through issuance of...
Wockhardt Q1 net loss shrinks to Rs 45 crore from previous fiscal loss of Rs 89.18 crore Medical Dialogues Bureau18 Aug 2019 9:30 AM ISTTotal income of the company stood at Rs 871.19 crore during the quarter under review, down 14.18 per cent, from Rs 1,015.14 crore reported in the...
Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent Medical Dialogues Bureau17 Aug 2019 9:13 AM ISTMorepen Labs' export sales in Q1'FY 2019-20 for Montelukast Sodium rose by 210 per cent and that of Atorvastatin Calcium by 57 per cent vis-a-vis the...
Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter Medical Dialogues Bureau16 Aug 2019 9:30 AM ISTMumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
Glenmark Pharma misses estimate; records profit of Rs 109.28 crore for June quarter Medical Dialogues Bureau14 Aug 2019 9:30 AM ISTGlenmark Pharma said the figures are not comparable as the last financial year included one-time forex gain of Rs 138.21 crore.New Delhi: Glenmark...
